U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336069) titled 'Shilangqing Smart Reading Aid for Improving Reading Ability in Children With Low Vision' on Jan. 02.
Brief Summary: This clinical trial aims to assess the efficacy and safety of the Shilangqing Smart Reading Aid, a head-mounted device integrating XR and AI technologies, in improving reading performance and quality of life among children with low vision. The study employs a multicenter, randomized, controlled design with two parallel groups: an experimental group using the Shilangqing device and a control group using traditional optical magnifiers. Participants will undergo a 12-week intervention period, with primary outcomes focusin...